Dr. Cory J. Bethmann, MD
Family Medicine (Family Medicine Physician)
- Medicare participating
At a glance
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 188
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
MO license 2011006543
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 188
- Services billed
- 212
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 130 | 128 |
| Established patient office or other outpatient visit, 30-39 minutes | 54 | 53 |
| Established patient office or other outpatient visit, 10-19 minutes | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in Springfield, MO | 43 |
| Cephalexin Other prescribers in Springfield, MO | 31 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Springfield, MO | 21 |
| Doxycycline Hyclate Other prescribers in Springfield, MO | 20 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Springfield, MO | 17 |
| Cefdinir Other prescribers in Springfield, MO | 16 |
| Tramadol Hcl Other prescribers in Springfield, MO | 13 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Springfield, MO | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 3 payments worth $178 in total to this clinician.
| Gilead Sciences, Inc. | $123 |
|---|---|
| AbbVie Inc. | $54.95 |
| Food and Beverage | $178 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 1 companies. The companies reported $621,079 in research payments for these studies, mostly to the institutions running them.
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
Eli Lilly and Company · Active, not recruiting · NCT06292013 - The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Eli Lilly and Company · Active, not recruiting · NCT06383390 - A phase 3B study to investigate the efficacy and safety of retatrutide once weekly in participants without type 2 diabetes who have obesity or overweight: a randomized, double-blind, placebo-controlled trial (TRIUMPH-8)
Eli Lilly and Company
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.